Corrigendum to "Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals"[Cancer Lett. 386 (2017)12-23]
Cancer Lett. 2021 Feb 1:498:251-252.
doi: 10.1016/j.canlet.2020.07.036.
Epub 2020 Aug 25.
1 Department of Microbial and Biochemical Pharmacy, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
2 Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
3 Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China.
4 Laboratory Animal Center, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, China.
5 Department of Microbial and Biochemical Pharmacy, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China. Electronic address: [email protected].